Controlled comparative clinical trial of hearing benefit outcomes for users of the Cochlear™ Nucleus® 7 Sound Processor with mobile connectivity

Objectives: To assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus ® 7 Sound Processor (SP), in experienced users of compatible cochlear implants from Cochlear Limited. Methods: A total of 37 adult participants were fitte...

Full description

Saved in:
Bibliographic Details
Published inCochlear implants international Vol. 20; no. 3; pp. 116 - 126
Main Authors Warren, Chris D., Nel, Esti, Boyd, Paul J.
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 04.05.2019
Subjects
Online AccessGet full text
ISSN1467-0100
1754-7628
1754-7628
DOI10.1080/14670100.2019.1572984

Cover

Abstract Objectives: To assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus ® 7 Sound Processor (SP), in experienced users of compatible cochlear implants from Cochlear Limited. Methods: A total of 37 adult participants were fitted with the Nucleus 7 SP and used the device for up to one year. Baseline speech recognition was assessed at the initial fitting session, using each participant's own SP, and Client Oriented Scale of Improvement (COSI) goals were identified. Speech recognition was measured after 3 months of device use and outcomes of the COSI and a non-validated Processor Comparison Questionnaire (PCQ) were collected. After 11 months, a subset of subjects were tested on speech recognition delivered via direct wireless streaming from an Apple ® smartphone to the SP and compatible hearing aid on the opposite side (if worn). Results: The COSI and PCQ instruments both indicated significant improvement in perceived subjective benefits in comparison to the participants' previous SPs. Direct streaming via an Apple mobile phone showed improvements when compared with the acoustic alone condition. Standard speech recognition in quiet and noise was equivalent to that obtained using a previous generation SP which uses the same basic processing as the Nucleus 7 Sound Processor. Conclusions: The incremental refinements provided by the Nucleus 7 Sound Processor provide real-world benefits in key areas such as upgraded wireless connectivity. The COSI proved to be an effective tool for individualized assessment of specific benefits that may not be addressed by more standardized instruments.
AbstractList Objectives: To assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus ® 7 Sound Processor (SP), in experienced users of compatible cochlear implants from Cochlear Limited. Methods: A total of 37 adult participants were fitted with the Nucleus 7 SP and used the device for up to one year. Baseline speech recognition was assessed at the initial fitting session, using each participant's own SP, and Client Oriented Scale of Improvement (COSI) goals were identified. Speech recognition was measured after 3 months of device use and outcomes of the COSI and a non-validated Processor Comparison Questionnaire (PCQ) were collected. After 11 months, a subset of subjects were tested on speech recognition delivered via direct wireless streaming from an Apple ® smartphone to the SP and compatible hearing aid on the opposite side (if worn). Results: The COSI and PCQ instruments both indicated significant improvement in perceived subjective benefits in comparison to the participants' previous SPs. Direct streaming via an Apple mobile phone showed improvements when compared with the acoustic alone condition. Standard speech recognition in quiet and noise was equivalent to that obtained using a previous generation SP which uses the same basic processing as the Nucleus 7 Sound Processor. Conclusions: The incremental refinements provided by the Nucleus 7 Sound Processor provide real-world benefits in key areas such as upgraded wireless connectivity. The COSI proved to be an effective tool for individualized assessment of specific benefits that may not be addressed by more standardized instruments.
To assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus 7 Sound Processor (SP), in experienced users of compatible cochlear implants from Cochlear Limited. A total of 37 adult participants were fitted with the Nucleus 7 SP and used the device for up to one year. Baseline speech recognition was assessed at the initial fitting session, using each participant's own SP, and Client Oriented Scale of Improvement (COSI) goals were identified. Speech recognition was measured after 3 months of device use and outcomes of the COSI and a non-validated Processor Comparison Questionnaire (PCQ) were collected. After 11 months, a subset of subjects were tested on speech recognition delivered via direct wireless streaming from an Apple smartphone to the SP and compatible hearing aid on the opposite side (if worn). The COSI and PCQ instruments both indicated significant improvement in perceived subjective benefits in comparison to the participants' previous SPs. Direct streaming via an Apple mobile phone showed improvements when compared with the acoustic alone condition. Standard speech recognition in quiet and noise was equivalent to that obtained using a previous generation SP which uses the same basic processing as the Nucleus 7 Sound Processor. The incremental refinements provided by the Nucleus 7 Sound Processor provide real-world benefits in key areas such as upgraded wireless connectivity. The COSI proved to be an effective tool for individualized assessment of specific benefits that may not be addressed by more standardized instruments.
To assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus® 7 Sound Processor (SP), in experienced users of compatible cochlear implants from Cochlear Limited.OBJECTIVESTo assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus® 7 Sound Processor (SP), in experienced users of compatible cochlear implants from Cochlear Limited.A total of 37 adult participants were fitted with the Nucleus 7 SP and used the device for up to one year. Baseline speech recognition was assessed at the initial fitting session, using each participant's own SP, and Client Oriented Scale of Improvement (COSI) goals were identified. Speech recognition was measured after 3 months of device use and outcomes of the COSI and a non-validated Processor Comparison Questionnaire (PCQ) were collected. After 11 months, a subset of subjects were tested on speech recognition delivered via direct wireless streaming from an Apple® smartphone to the SP and compatible hearing aid on the opposite side (if worn).METHODSA total of 37 adult participants were fitted with the Nucleus 7 SP and used the device for up to one year. Baseline speech recognition was assessed at the initial fitting session, using each participant's own SP, and Client Oriented Scale of Improvement (COSI) goals were identified. Speech recognition was measured after 3 months of device use and outcomes of the COSI and a non-validated Processor Comparison Questionnaire (PCQ) were collected. After 11 months, a subset of subjects were tested on speech recognition delivered via direct wireless streaming from an Apple® smartphone to the SP and compatible hearing aid on the opposite side (if worn).The COSI and PCQ instruments both indicated significant improvement in perceived subjective benefits in comparison to the participants' previous SPs. Direct streaming via an Apple mobile phone showed improvements when compared with the acoustic alone condition. Standard speech recognition in quiet and noise was equivalent to that obtained using a previous generation SP which uses the same basic processing as the Nucleus 7 Sound Processor.RESULTSThe COSI and PCQ instruments both indicated significant improvement in perceived subjective benefits in comparison to the participants' previous SPs. Direct streaming via an Apple mobile phone showed improvements when compared with the acoustic alone condition. Standard speech recognition in quiet and noise was equivalent to that obtained using a previous generation SP which uses the same basic processing as the Nucleus 7 Sound Processor.The incremental refinements provided by the Nucleus 7 Sound Processor provide real-world benefits in key areas such as upgraded wireless connectivity. The COSI proved to be an effective tool for individualized assessment of specific benefits that may not be addressed by more standardized instruments.CONCLUSIONSThe incremental refinements provided by the Nucleus 7 Sound Processor provide real-world benefits in key areas such as upgraded wireless connectivity. The COSI proved to be an effective tool for individualized assessment of specific benefits that may not be addressed by more standardized instruments.
Author Warren, Chris D.
Nel, Esti
Boyd, Paul J.
Author_xml – sequence: 1
  givenname: Chris D.
  surname: Warren
  fullname: Warren, Chris D.
  email: cwarren@cochlear.com
  organization: Cochlear Ltd
– sequence: 2
  givenname: Esti
  surname: Nel
  fullname: Nel, Esti
  organization: Cochlear Ltd
– sequence: 3
  givenname: Paul J.
  surname: Boyd
  fullname: Boyd, Paul J.
  organization: Cochlear Ltd
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30714500$$D View this record in MEDLINE/PubMed
BookMark eNqFkUuOVCEUhonpjv3QJWgYOrklXLivONFUfCUd20QdEy4cLAwXSuB2p-buwB24gF6ES3ElclNVEwf2BM7g-85J_v8CnfjgAaEnlKwo6clzytuOUEJWNaHDijZdPfT8ATqnXcOrrq37kzIXplqgM3SR0jdCGOUNf4jOGOnKRMg5-rkOPsfgHGiswrSVUWZ7A1g5662SDudoyxsM3oCM1n_FI3gwNuMw5yJAwiZEPCeIaaHyBvA6qI0r9J8fv_CHWTmY0-873OFPYfYaf4xBQUpFurV5g6cwWlfuBe9BldM27x6hUyNdgseH_xJ9efP68_pddXX99v361VWlWNvmSnINzBhuaNNyRcemHXRr9Nhr3dKBj1JKxihpelC6lazmPe3HQRVAatYwxS7Rs_3ebQzfZ0hZTDYpcE56CHMSNe2GEtLAWUGfHtB5nECLbbSTjDtxDLIAL_aAiiGlCEYom0uUS7rSOkGJWGoTx9rEUps41Fbs5h_7eOA-7-Xes760MMnbEJ0WWe5ciCZKr2wS7P8r_gIk2LMJ
CitedBy_id crossref_primary_10_1080_14992027_2024_2337075
crossref_primary_10_1080_14670100_2024_2415193
crossref_primary_10_1007_s00405_022_07324_8
crossref_primary_10_3389_fnins_2022_976767
crossref_primary_10_1007_s00405_020_06372_2
crossref_primary_10_1080_14670100_2023_2233203
crossref_primary_10_1155_2021_1679907
crossref_primary_10_1371_journal_pone_0307044
crossref_primary_10_1007_s00106_023_01341_7
crossref_primary_10_1007_s00106_023_01342_6
crossref_primary_10_1002_ohn_657
crossref_primary_10_1177_01455613241272467
Cites_doi 10.1055/s-0034-1390301
10.3109/14992027.2014.895431
10.1044/jshd.2701.62
10.1007/s00405-013-2381-8
10.1177/2331216516673639
10.3766/jaaa.25.2.10
10.3766/jaaa.15012
10.1179/cim.2007.8.1.29
10.1179/1754762814Y.0000000097
10.1016/j.otohns.2008.02.012
10.3109/14992027.2010.509113
10.1097/AUD.0b013e3182251a0e
10.1016/j.ijporl.2016.02.004
10.1097/MAO.0000000000000903
10.1097/AUD.0b013e31828576fb
10.1097/AUD.0b013e31824b9e21
10.1097/MAO.0000000000000781
ContentType Journal Article
Copyright 2019 Cochlear Europe 2019
Copyright_xml – notice: 2019 Cochlear Europe 2019
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1080/14670100.2019.1572984
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1754-7628
EndPage 126
ExternalDocumentID 30714500
10_1080_14670100_2019_1572984
1572984
Genre Article
Journal Article
GroupedDBID ---
002
0R~
1OC
1~B
36B
4.4
53G
5GY
6PF
AAGDL
AALUX
AAMIU
AAPUL
AAQRR
AAWTL
ABBKH
ABDBF
ABEIZ
ABIJN
ABIVO
ABLIJ
ABUPF
ABWVI
ABXYU
ACENM
ACIEZ
ACUHS
ADCVX
AECIN
AFRVT
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
AMDAE
ARJSQ
BLEHA
BOHLJ
CCCUG
CS3
E01
EBD
EBS
EJD
EMB
EMOBN
ESX
F5P
H13
HCLVR
HZ~
IPNFZ
KYCEM
LAW
LJTGL
M4Z
OIG
P2P
P76
P7A
P7B
QRW
RIG
RNANH
RVRKI
RYL
SV3
TASJS
TBQAZ
TERGH
TFL
TFW
TUROJ
TUS
UEQFS
XV2
AAYXX
CITATION
0BK
29F
31~
8-1
ACKZS
ACXQS
ADFOM
ADFZZ
ADYSH
AEIIZ
AFBPY
AJAOE
CZDIS
DRXRE
DWTOO
M46
NPM
7X8
ID FETCH-LOGICAL-c366t-a4de3ff4f1564c1b569d6fdb8dd6194baaa331058ecd6a324818b9cdb8ad353c3
ISSN 1467-0100
1754-7628
IngestDate Fri Sep 05 13:30:52 EDT 2025
Wed Feb 19 02:31:57 EST 2025
Wed Oct 01 04:26:24 EDT 2025
Thu Apr 24 23:03:51 EDT 2025
Mon Oct 20 23:48:47 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Cochlear implant
Nucleus 7 Sound Processor
Client oriented scale of improvement
Upgrade study
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c366t-a4de3ff4f1564c1b569d6fdb8dd6194baaa331058ecd6a324818b9cdb8ad353c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
PMID 30714500
PQID 2179500943
PQPubID 23479
PageCount 11
ParticipantIDs informaworld_taylorfrancis_310_1080_14670100_2019_1572984
proquest_miscellaneous_2179500943
pubmed_primary_30714500
crossref_citationtrail_10_1080_14670100_2019_1572984
crossref_primary_10_1080_14670100_2019_1572984
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-05-04
PublicationDateYYYYMMDD 2019-05-04
PublicationDate_xml – month: 05
  year: 2019
  text: 2019-05-04
  day: 04
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Cochlear implants international
PublicationTitleAlternate Cochlear Implants Int
PublicationYear 2019
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References CIT0010
CIT0020
CIT0001
CIT0012
CIT0011
Dillon H. (CIT0006) 1997; 8
Cox R.M. (CIT0002) 1991; 2
Revit L.J. (CIT0016) 2007
CIT0003
CIT0014
CIT0013
CIT0005
CIT0004
CIT0015
CIT0007
CIT0018
CIT0017
CIT0009
CIT0008
CIT0019
References_xml – ident: CIT0017
  doi: 10.1055/s-0034-1390301
– ident: CIT0010
  doi: 10.3109/14992027.2014.895431
– ident: CIT0014
  doi: 10.1044/jshd.2701.62
– ident: CIT0011
  doi: 10.1007/s00405-013-2381-8
– volume: 2
  start-page: 134
  year: 1991
  ident: CIT0002
  publication-title: The Journal of the American Academy of Audiology
– volume: 8
  start-page: 27
  issue: 1
  year: 1997
  ident: CIT0006
  publication-title: The Journal of the American Academy of Audiology
– ident: CIT0008
  doi: 10.1177/2331216516673639
– ident: CIT0013
  doi: 10.3766/jaaa.25.2.10
– ident: CIT0012
  doi: 10.3766/jaaa.15012
– ident: CIT0018
  doi: 10.1179/cim.2007.8.1.29
– ident: CIT0005
  doi: 10.1179/1754762814Y.0000000097
– year: 2007
  ident: CIT0016
  publication-title: The Hearing Review
– ident: CIT0001
  doi: 10.1016/j.otohns.2008.02.012
– ident: CIT0007
  doi: 10.3109/14992027.2010.509113
– ident: CIT0003
  doi: 10.1097/AUD.0b013e3182251a0e
– ident: CIT0015
  doi: 10.1016/j.ijporl.2016.02.004
– ident: CIT0020
  doi: 10.1097/MAO.0000000000000903
– ident: CIT0004
  doi: 10.1097/AUD.0b013e31828576fb
– ident: CIT0009
  doi: 10.1097/AUD.0b013e31824b9e21
– ident: CIT0019
  doi: 10.1097/MAO.0000000000000781
SSID ssj0031454
Score 2.2189467
Snippet Objectives: To assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus ® 7 Sound...
To assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus 7 Sound Processor (SP),...
To assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus® 7 Sound Processor (SP),...
SourceID proquest
pubmed
crossref
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 116
SubjectTerms Client oriented scale of improvement
Cochlear implant
Nucleus 7 Sound Processor
Upgrade study
Title Controlled comparative clinical trial of hearing benefit outcomes for users of the Cochlear™ Nucleus® 7 Sound Processor with mobile connectivity
URI https://www.tandfonline.com/doi/abs/10.1080/14670100.2019.1572984
https://www.ncbi.nlm.nih.gov/pubmed/30714500
https://www.proquest.com/docview/2179500943
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1754-7628
  dateEnd: 20241102
  omitProxy: true
  ssIdentifier: ssj0031454
  issn: 1467-0100
  databaseCode: ABDBF
  dateStart: 20040301
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NjtMwELZKV0JcEP-UPxmJcqmypLHz02O3tFqh3XKglXqLYscWlUqytOkBzrwBZy48AA_Bo_AkjP_SVBTtwiWK3Di1Ol_HM-NvZhB6ETGZZ0kQezQRAhwUEXgsY1TdMU4kjYVUycnn0-h0Tt8swkWr9a3BWtpW7Jh_PphX8j9ShTGQq8qS_QfJ1i-FAbgH-cIVJAzXK8l4ZHjmK5FbLrmp4l1nO5qWHMYc1Dw7BppNLqteua1ggtC1GHoqTrFxXIFRyd-rThKaBEG7w6A3VRWPt5vuKOgOx7249041YnIJBjBdR3I_lAzUi-KwF1qDLqu942L3VpWUudLMm2UzErmL6q_XoqhrHuzYyFPDJRiDPqrjB-Wn3FEb7dmWDV6ofKnQM-2Grb6NQ-qBPjYqWBwYs0o68BtgJA2N2zepmn_sBIY6qfYB8Dh9xeEbHPdDcCVMR7r9ytvTt-lkfnaWzsaL2cuLj55qSqYO722HlmvoKIAF-W10NDx5fTJxWz3pU91mr16xSxFL_FcHv3nP-Nkrjft3B0cbOrNb6Kb1UPDQwO02aoniDrp-bjkYd9HXHepwA3XYoQ5r1OFSYos6bFGHHeowLAhr1KmnAHXY4ePXl-_Y4u3nDxxjjTVcYw0rrGGDNdzE2j00n4xno1PPtvbwOImiystoLoiUVKpaRbzPwmiQRzJnSZ6rsBrLsoyA4xEmgudRBkY_2JVswOGBLCch4eQ-ahdlIR4i7EtCk5DGPBAZpeAg01BGfs79gHMJtlYHUfebp9zWvVftV1Zp35bHdaJKlahSK6oOOq6nXZjCL5dNGDQFmlY64iZNe5yUXDL3uZN-CupdndllhSi3mzSADTPU9N8OemBgUS-HqORD-PDRFWY_Rjd2_78nqF2tt-IpmNMVe2ZB_Rv20cxd
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Controlled+comparative+clinical+trial+of+hearing+benefit+outcomes+for+users+of+the+Cochlear%E2%84%A2+Nucleus%C2%AE+7+Sound+Processor+with+mobile+connectivity&rft.jtitle=Cochlear+implants+international&rft.au=Warren%2C+Chris+D&rft.au=Nel%2C+Esti&rft.au=Boyd%2C+Paul+J&rft.date=2019-05-04&rft.issn=1754-7628&rft.eissn=1754-7628&rft.volume=20&rft.issue=3&rft.spage=116&rft_id=info:doi/10.1080%2F14670100.2019.1572984&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1467-0100&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1467-0100&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1467-0100&client=summon